baber/WOPTO huggingface dataset:
Patent DK-0584805-T3 (DK)
Inventor: RUPPERT HEINRICH WILHELM
IPC: A24C5/40
Filed: 1993-08-25
Granted: 1998-05-04
Abstract: A tobacco product for producing a home-made cigarette, consisting of one or more tobacco portion(s) (47) comprising in each case at least two partial quantities (48 or 50) and being held together by inner and/or outer fixing means (49), each partial quantity (48 or 50) containing approximately the quantity of tobacco required for one cigarette, and the outer surface of the tobacco portion (47) and/or partial quantities (50) being permeable to air in such a way that it is impossible as such to draw through it and it is thus unsmokable. The tobacco portion (47) is formed either by two or more partial quantities (50) of rod-like shape in each case and connected, in particular bonded, to one another to form a rod belt (51), or by a flat oval tobacco unit comprising two or more partial quantities (48). The tobacco portion (47) is held together in each case in such a way that, when one partial quantity (48 or 50) is separated, this and the partial quantity immediately adjoining it are inevitably destroyed or broken up whilst removing the inner holding-together thereof. A stuffing apparatus is provided, in adaptation to the abovementioned tobacco, with a magazine (52) and a separating knife (1) for separating the individual partial quantities (48 or 50). <IMAGE>
Patent DK-0603557-T3 (DK)
Inventor: JACKSON MARGIE FAYE
IPC: C08F10/00
Filed: 1993-11-22
Granted: 1998-02-16
Abstract: Catalytic compositions and catalytic processes are provided. The catalytic compositions are produced by the process that comprises contacting an organonickel compound with a cyclicazacarbyl compound. Optionally, one or more catalytic promoters can be present in the catalytic compositions. Additionally, one or more olefins can be contacted with one or more of these catalytic compositions to form oligomerization products and/or polymerization products.
Patent DK-0645219-T3 (DK)
Inventor: HUANG CHIU-FENG
IPC: F16B2/16
Filed: 1994-03-24
Granted: 1998-05-04
Abstract: The clamping device includes two clamping units. At least one of the clamping units includes a sheave having a pinion portion biased toward the other of the clamping units so as to hold an elongated piece between the clamping units. A rack member engages the pinion portion of the sheave. Preferably, each of the clamping units has a frictional clamping surface which presses against the elongated piece.
Patent DK-0701623-T3 (DK)
Inventor: DAWSON MICHAEL JOHN
IPC: C12P19/26
Filed: 1994-06-08
Granted: 1997-08-25
Abstract: A method for the preparation of N-acetyl-D-neuraminic acid (NANA) from N-acetyl-D-glucosamine (NAG) is described.
Patent DK-0710218-T3 (DK)
Inventor: YANG XIN
IPC: C02F3/00
Filed: 1994-07-18
Granted: 2002-10-28
Abstract: Multi-purpose demonstration device includes carrier (10) accommodating inner space (13) enclosed by surrounding plates (11). A biological object is arranged in inner space (13). The bedding medium (30) fills up at least part of the inner space (13). The bedding medium (30) comprises a solidifying two-component silicon elastomer. Preferably at least part of surrounding plates (11) of the carrier (10) are provided with a set-off zone (12) (preferably the set-off zones (12) are made of methyl-methacrylate). Preferably at least part of the surrounding plates (11) forming the carrier (10) are made of glass.
Patent DK-0711722-T3 (DK)
Inventor: BORCHARDT HORST
IPC: B65G69/28
Filed: 1995-10-14
Granted: 1998-09-07
Abstract: A ramp member for a loading dock has a bridge member with a forward and and rearward end. The rearward end is connected to the loading dock so as to be pivotable about a horizontal axis. An extension plate is connected with a first end by a pivot connection to the forward end of the bridge member such that the extension plate is pivotable from a folded position into a working position. In the rest position of the bridge member the extension plate is folded and rests on an abutment for supporting the bridge member. The first end of the extension plate has a projection extending over its entire length. The projection has a cross-sectional shape of a circular ring sector with an inner and an outer radius. The outer surface of the projection is defined by the outer radius and the inner surface is defined by the inner radius. A profiled member with an interior space is connected to the forward end of the bridge member and extends over the entire length of the pivot connection. The projection extends into the interior space of the profiled member. The profiled member has a bead on which the projection is pivotably supported with its inner surface. The bead defines the pivot axis of the pivot connection. The inner radius of the projection and the exterior radius of the bead are identical.
Patent DK-0738147-T3 (DK)
Inventor: STUTZMANN JEAN-MARIE
IPC: A61P1/16
Filed: 1995-01-09
Granted: 2000-07-10
Abstract: PCT No. PCT/FR95/00023 Sec. 371 Date Jul. 11, 1996 Sec. 102(e) Date Jul. 11, 1996 PCT Filed Jan. 9, 1995 PCT Pub. No. WO95/19170 PCT Pub. Date Jul. 20, 1995A method for the treatment of mitochondrial diseases, including Kearns-Sayre syndrome, MERRF syndrome, MELAS syndrome and Leber's disease, is carried out by administering to a patient in need of treatment an effective amount of riluzole or a pharmaceutically acceptable salt thereof.
Patent DK-0787249-T3 (DK)
Inventor: HOLLIS THOMAS J
IPC: F01M5/00
Filed: 1995-09-12
Granted: 1999-05-03
Abstract: A temperature control system in a liquid cooled internal combustion engine equipped with a radiator. The system comprises a flow control valve, first and second sensors and an engine computer. The flow control valve controls flow of a temperature control fluid through a passageway. The flow control valve has a first state for preventing or inhibiting the flow and a second state for allowing the flow. The first sensor detects the temperature of the temperature control fluid and the second sensor detects ambient air temperature. The engine computer receives signals from the first and second sensors and compares the signals to a set of predetermined values which define a curve. Preferably a portion of the curve has a non zero slope. The engine computer determines a desired state of the valve based on the comparison and produces control signals for actuating the valve into the desired state.
Patent DK-0809700-T3 (DK)
Inventor: GISSMANN LUTZ
IPC: C12N7/00
Filed: 1995-10-09
Granted: 2006-09-18
Abstract: In recombinant papilloma virus-like particles (VLP) derived from expression of viral structural proteins L1 and/or L2, the new feature is that at least one segment of these proteins is deleted but ability to form VLP is retained. Also new are: (1) fusion proteins (FP), esp. for prepn. of hybrid papilloma VLP (HVLP) consisting of a deleted L1 and/or L2 protein of a human papilloma virus (HPV) plus another protein (A) or its fragment; and (2) proteins (B), partic. for prepn. of HVLP, from which at least one L1/L2 segment has been deleted.
Patent DK-0781781-T3 (DK)
Inventor: TSUJIHARA KENJI
IPC: C08B37/00
Filed: 1996-12-23
Granted: 2001-11-26
Abstract: A camptothecin derivative comprising a compound of the formula ÄIÜ:   <CHEM> wherein R<1>, R<2>, R<3>, R<4> and R<5> are (A) adjacent two groups combine to form alkylene, or both are H, and one of the remaining three groups is -Xn-Alkm-R<6>, and the other two are H, alkyl or halogen, or (B) adjacent two groups combine to form alkylene, and one of the carbon atoms of said alkylene group is substituted by -Xn-Alkm-R<6>, and the remaining three groups are H, alkyl or a halogen, and one or two -CH2- of the alkylene in (A) or (B) may optionally be replaced by -O-, -S- or -NH-, X is -O- or -NH-, Alk is alkylene, R<6> is -NH2, <CHEM> or -OH, m and n are both 0 or 1, or m is 1 and n is 0, which camptothecin compound is bound to a polysaccharide having carboxyl groups via an amino acid or a peptide, or a pharmaceutically acceptable salt thereof. Said camptothecin derivatives show enhanced antitumor activities but few side effects and are useful as a medicament.
Patent DK-0853627-T3 (DK)
Inventor: WILLIAM J CHRIST
IPC: C07H13/06
Filed: 1996-06-05
Granted: 2004-06-01
Abstract: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
Patent DK-0838424-T3 (DK)
Inventor: PEPIN RONALD R
IPC: B66B13/14
Filed: 1997-10-24
Granted: 2002-05-27
Abstract: An apparatus and method for providing an elevator door performance result of an elevator door in an elevator door system which normally operates sequentially from state-to-state in a closed loop sequential chain of normal operating states is disclosed. A plurality of parameter signals provided by the elevator door system is monitored by the apparatus. The apparatus comprises: a door state sequencer for providing a performance measure; a module for providing a reference measure and an acceptable range; and an abnormal detection module for analyzing the door performance measure. <IMAGE>
Patent DK-0891341-T3 (DK)
Inventor: DYKER HUBERT
IPC: A01N43/88
Filed: 1997-03-17
Granted: 2003-04-22
Abstract: PCT No. PCT/EP97/01325 Sec. 371 Date Sep. 18, 1998 Sec. 102(e) Date Sep. 18, 1998 PCT Filed Mar. 17, 1997 PCT Pub. No. WO97/36883 PCT Pub. Date Oct. 9, 1997The invention relates to novel (1,3,4)-oxadiazine derivatives of formula (I), to a process and intermediates for their preparation, and to their usefulness as pesticides, in particular as anthelminthics, insecticides, acaricides, and nematicides.
Patent DK-0956774-T3 (DK)
Inventor: HIGASHIYAMA KENICHI
IPC: A23L1/30
Filed: 1997-10-09
Granted: 2008-03-31
Abstract: Edible oil containing arachidonic acid obtained from microorganisms belonging to the subgenus  Mortierella  of the genus  Mortierella  and being capable of producing arachidonic acid are provided. The oil contain little unsaponifiable matters and, above all, the smallest possible amount of sterol with cyclopropane structure which have not been recognized as food components, and are suitable for the production of foods, in particular, infant formula.  Arachidonic acid-containing edible oil originating in microorganisms containing not more than 0.8% by weight, preferably not more than 0.6% by weight of unsaponifiable matters and 20% by weight or more of arachidonic acid. Further, these edible oil contain not more than 0.3% by weight, preferably not more than 0.15% by weight of 24,25-methylenecholest-5-en-3  ²  -ol. The microorganisms are those belonging to the subgenus  Mortierella  of the genus  Mortierella  and being capable of producing arachidonic acid. These microorganisms belong to the species  alpina  of the genus  Mortierella.  Foods including the arachidonic acid-containing edible oil. Formula for premature infants, formula for infants, foods for infants, and foods for pregnant women and nursing mothers, including the arachidonic acid-containing edible oil.
Patent DK-1043317-T3 (DK)
Inventor: OHKUCHI MASAO
IPC: C07D213/00
Filed: 1998-11-09
Granted: 2009-07-06
Abstract: A pyridazine derivative represented by the following formula (1):   
wherein 
R 1  
represents a phenyl or pyridyl group which may be substituted by 1 to 3 substituents selected from a halogen atom and a C 1-6  alkoxyl group, 
R 2  
represents a phenyl group substituted at least at 4-position by a C 1-6  alkoxyl group, C 1-6  alkylthio group, a C 1-6  alkylsulfinyl group, or a C 1-6  alkylsulfonyl group, and optionally has one or more substituents at the other position by 1 or 2 substituents selected from a halogen atom, a C 1-6 alkoxyl group, C 1-6  alkylthio group, a C 1-6  alkylsulfinyl group, or a C 1-6  alkylsulfonyl group, 
R 3  
represents a C 1-6  alkoxyl group, a fluorinated C 1-6  alkyl group, C 1-6  alkyl group or a C 3-8  cycloalkyl group, 
A 
represents a single bond or linear or branched C 1-6  alkylene group or C 2-9  alkenylene group, 
X 
represents an oxygen atom or a sulfur atom; 
or a salt thereof.
Patent DK-1073694-T3 (DK)
Inventor: LEVY LUIS W
IPC: A23L1/275
Filed: 1999-04-14
Granted: 2003-10-20
Abstract: Trans-xanthophyll ester concentrates having a trans-xanthophyll ester content of at least four times greater and preferably at least nine times greater than the cis-xanthophyll ester content are obtained. Xanthophyll ester concentrates having a total xanthophyll ester content of at least 40 wt. % and preferably greater than about 55 wt. % are also obtained. A method of obtaining a trans-xanthophyll ester concentrate of high purity includes contacting plant material containing xanthophyll esters with a hydrocarbon solvent for a time sufficient to extract xanthophyll esters from the plant material, separating the hydrocarbon solvent and extract dissolved therein from the remaining plant material, evaporating the hydrocarbon solvent from the dissolved extract to obtain a crude xanthophyll ester concentrate, admixing the crude xanthophyll ester concentrate with an alcohol at approximately ambient temperature to dissolve non-xanthophyll impurities and cis-xanthophyll esters from the concentrate and removing the alcohol containing impurities and cis-xanthophyll esters from the crude trans-xanthophyll concentrate to obtain a purified trans-xanthophyll ester concentrate. By using only the corollas of marigold flowers, lutein ester concentrates of high purity are obtained with pesticide residues absent from the concentrate at parts per billion detection levels.
Patent DK-1135153-T3 (DK)
Inventor: AGUET MICHEL
IPC: A61P9/00
Filed: 1999-11-18
Granted: 2005-08-15
Abstract: The present application describes methods of inhibiting or stimulating angiogenesis in a mammal comprising administering to the mammal an effective amount of an Eph receptor antagonist or agonist, respectively. Articles of manufacture for use in relation to these methods are also described.
Patent DK-1140149-T3 (DK)
Inventor: GIANNI ALESSANDRO MASSIMO
IPC: A61P35/02
Filed: 1999-12-30
Granted: 2007-02-19
Abstract: The invention relates to the field of hematopoietic CD34 +  cell mobilization. In particular, this invention relates to a method for increasing the mobilization of pluripotent hematopoietic CD34 +  cells by administration of human growth hormone or one of its derivates to the individual.
Patent ES-2212760-T3 (ES)
Title: Procedimiento y dispositivo para evitar el resbalamiento de una correa.
Inventor: MAURER MICHAEL DR
IPC: F02N11/04
Filed: 2000-03-01
Granted: 2004-08-01
Abstract: Procedimiento para reducir el resbalamiento de una correa que une un alternador con un árbol de un motor, donde el alternador puede hacerse funcionar también como motor de accionamiento, caracterizado porque se calcula una medida del riesgo de resbalamiento de la correa y porque, al sobrepasarse un valor límite, se solicita el alternador, concretamente se le frena o se le acelera, de tal manera que se reduzca un resbalamiento o el riesgo de un resbalamiento.
Patent ES-2173834-T3 (ES)
Title: Procedimiento para la fabricacion de carcasas o peanas compuestas de metal.
Inventor: BAUER KARL-HEINZ
IPC: B29C45/14
Filed: 2000-03-03
Granted: 2002-11-01
Abstract: Procedimiento para la fabricación de carcasas o peanas compuestas de metal, las cuales presentan un encastre de indicación compuesto por plástico transparente, que comprende las fases siguientes del procedimiento: fabricación de la carcasa o peana (1, 3) como pieza en bruto (4, 5) forjada o fundida, ejecución de una escotadura (6) para el encastre del indicador mediante un punzón de estampación en una instalación de estampación, elevando (7) la superficie (8) trasera de pared en la dirección de la estampación, contracción de la escotadura (6) a través de un desbarbado en cuña de las paredes (9) de delimitación de la escotadura (6), inyección del plástico (2) transparente en la escotadura (6), y, en su caso, en una forma unida a la escotadura (6), al objeto de formar un cuello (10) en una superficie de pared (11) en la parte delantera según la dirección de la estampación, eliminación de la superficie trasera de pared (8) y dela elevación (7) en un espesor prefijado (12), lo que ocasiona unaliberación de la escotadura (6), o bien del plástico (2) transparente.
Patent ES-2235811-T3 (ES)
Inventor: VASSILIOU MARIE-MICHELE
IPC: H04W4/029
Filed: 2000-03-23
Granted: 2005-07-16
Abstract: The service setting of the terminal user selection has a mechanisms to select services (St1) for a terminal user. Services a selected by the network operator setting the terminal services (I1 to I7) following the user behaviour.
Patent ES-2219322-T3 (ES)
Title: Condensacion fraccionado de una mezcla gaseosa de productos que contiene acido acrilico.
Inventor: THIEL JOACHIM
IPC: B01D3/26
Filed: 2000-02-28
Granted: 2004-12-01
Abstract: Procedimiento de condensación fraccionada de una mezcla gaseosa de productos, que contiene ácido acrílico, que proviene de una oxidación parcial en fase gaseosa, catalizada de manera heterogénea, de precursores con 3 átomos de carbono del ácido acrílico con oxígeno molecular, en una columna de separación que contiene platos de corriente transversal, que se han hecho estancos hidráulicamente, como estructuras internas eficaces en cuanto a la separación, caracterizado porque se utiliza como columna de separación una columna tal que contiene, de abajo hacia arriba, primero platos dual-flow y a continuación de lo anterior platos de corriente transversal, que se han hecho estancos hidráulicamente, como estructuras internas eficaces en cuanto a la separación.
Patent ES-2248096-T3 (ES)
Inventor: NUNOMURA KIYOTADA
IPC: C12Q1/6865
Filed: 2000-07-21
Granted: 2006-03-16
Abstract: Methods useful for improving results obtained with enzyme-based polynucleotide amplification reactions. More particularly, the invented methods are useful for: (1) promoting amplification of template-specific products such that the amount of amplicon produced reflects the pre-amplification amount of analyte, even in reactions primed with low levels of analyte polynucleotide; (2) facilitating biological specimen processing such that the amount of amplicon produced in subsequent amplification reactions will be substantially independent of the efficiency of analyte polynucleotide isolation from the specimen; and (3) controlling the amount of analyte amplicon produced in the amplification reaction.
Patent ES-2230143-T3 (ES)
Inventor: HULME CHRISTOPHER
IPC: C07B61/00
Filed: 2000-08-03
Granted: 2005-05-01
Abstract: A method for preparing a N-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
Patent ES-2197121-T3 (ES)
Inventor: BROWN NEIL
IPC: D21H17/67
Filed: 2000-10-16
Granted: 2004-01-01
Abstract: Aluminium hydroxide of high whiteness is produced by (i) heating aluminium hydroxide obtained from the Bayer process to a temperature of 300 to 700° C. (ii) dissolving the soluble fraction of the thus obtained activated product at 85 to 275° C. in aqueous sodium hydroxide to form a sodium aluminate liquor containing an undissolved residue of very fine boehmite, (iii) filtering said sodium aluminate liquor to obtain a clear solution of sodium aluminate supersaturated with respect to dissolved alumina, (iv) cooling said clear solution to 50 to 80° C. and seeding with crystallized aluminium hydroxide to induce further crystallization, and (v) separating, washing and drying the produced aluminium hydroxide crystals.
Patent ES-2202209-T3 (ES)
Title: Viricida contra la hepatitis a.
Inventor: VON RHEINBABEN FRIEDRICH
IPC: A01N31/02
Filed: 2000-12-14
Granted: 2004-04-01
Abstract: La utilización de una composición para destruir los virus de la hepatitis A, basada en uno o más alcoholes acuosos, que contiene 50 a 97% en peso de etanol, en relación con el total de la composición, y el resto hasta el 100% de la cantidad total siendo agua y, opcionalmente, coadyuvantes seleccionados entre perfumes, agentes reengrasantes y componentes tensioactivos, estando la composición exenta de sustancias activas que contienen cloro y/o que liberan cloro.
Patent ES-2260095-T3 (ES)
Title: Dispositivo recargable con medios para contar.
Inventor: DUNN PHILIP M
IPC: A61M15/00
Filed: 2000-12-19
Granted: 2006-11-01
Abstract: Un montaje de dispositivo médico recargable que comprende una unidad de recarga y una unidad de base adaptada para acoplarse con la unidad de recarga, y medios para contar el número de unidades de recarga nuevas que han sido acopladas con la unidad de base sin contar repetidamente la misma unidad de recarga, caracterizado por que la unidad de base comprende medios para i) inhabilitar la unidad de base, o ii) impedir el acoplamiento de una unidad de recarga nueva, después de que ha sido utilizado un número predeterminado de recargas nuevas con la unidad de base.
Patent ES-2264946-T3 (ES)
Inventor: STAHL BERND
IPC: A23L29/30
Filed: 2000-11-10
Granted: 2007-02-01
Abstract: Provided is a carbohydrate mixture comprising at least one modified carbohydrate from a base body and a carbohydrate residue coupled therewith. The base body concerned is either a digestible glucose-containing carbohydrate in the form of a digestible glucan or a non-digestible reserve carbohydrate, skeletal carbohydrate or a low-molecular component thereof. By coupling the base body with a carbohydrate residue, the glucose release from the inventive carbohydrate mixture is reduced by at least 10%, determined in an in-vivo digestion system on the basis of pancreatine and compared with a carbohydrate mixture containing the same amount by weight of non-modified carbohydrates. By means of the inventive carbohydrate mixture, the postprandial blood glucose concentration after eating can be moderated. The glucose can thus be metabolized by diabetics in spite of the existing lack of insulin. The inventive carbohydrate mixtures can be used in food for diabetics and in pharmaceuticals.
Patent ES-2258037-T3 (ES)
Title: Androgenos sustituidos con 14,15-beta-metilen.
Inventor: LEYSEN DIRK
IPC: A61K31/569
Filed: 2000-11-29
Granted: 2006-08-16
Abstract: Un compuesto que satisface la fórmula estructural donde R1 es O, (H, H), (H, OR) o NOR, siendo R hidrógeno, alquilo (C1-6) o acilo (C1-6); R2 es hidrógeno o alquilo (C1-6); R3 es hidrógeno o R3 es alquilo (C1-6), alquenilo (C2-6) o alquinilo (C2-6), cada uno eventualmente substituido por halógeno R4 es hidrógeno, alquilo (C1-6) o alquenilo (C2-6); R5 es alquilo (C1-6); R6 es hidrógeno, halógeno o alquilo (C1-4); R7 es hidrógeno o alquilo (C1-6); R8 es hidrógeno, halógeno o alquilo (C1-6); R9 y R10 son independientemente hidrógeno, o R9 y R10 son independientemente alquilo (C1-6), alquenilo (C2-6), cicloalquilo (C3-6), cicloalquenilo (C5-6) o alquinilo (C2-6), cada uno eventualmente substituido por alcoxi (C1- 4) o halógeno; R11 es hidrógeno, SO3H o acilo (C1-15), y las líneas discontinuas indican dobles enlaces eventuales, seleccionados entre un doble enlace 4, 5(10) o 11 o un sistema diénico 4, 9 o 4, 11, con la condición de que, cuando R1 sea O, R2 sea H, R3 sea H o alquilo (C1- 6), R4 sea H, R5 sea metilo, R6 sea H, R7 sea H, R8 sea H, R9 sea H, R10 sea H y haya un doble enlace 4 solo, R11 no pueda ser H.